Oncology hospital Vsetin
The study conducted in the oncological department in the hospital in Vsetin
under the leadership of the doctor of medical sciences Zdenek Yanachek, proves the exceptional effect of the
The distribution of patients according of their cancer diagnosis:
|Malignant melanoma||2 patients|
|Malignant disease of kidneys||1 patients|
|Malignant disease of the breast||12 patients|
|Malignant disease of the colon||7 patients|
|Malignant disease of the uterus||1 patients|
The number of studied patients: 23 patients
Dosage: 4 capsules per day (4 х 50 = 200 mg)
During the treatment the patients rated their health and the effect of the preparation PENOXAL positively. Haven’t been any side effects and allergic reaction during the 3-months treatment. The patients felt good during the use. Among the patients with the breast cancer have been 8 women using the preparation PENOXAL during the chemotherapy and it helped them obviously to deal with this therapy without any serious complications which could lead to adjustment of chemotherapy.
Side effects during the use of the preparation PENOXAL:
At one patient with the breast cancer diagnosis who has finished the course of chemotherapy during the process of use the preparation PENOXAL 4 capsules per day appeared intestinal disorders of the character of diarrhea. After the reducing the dosage up 2 capsules per day the disorders have passed.
While receiving the preparation PENOXAL have studied the KO, CRP indicators, liver samples, urea, creatinine corresponding the tumorial markers. We can conclude that there aren’t any worsening in laboratory indicators and in the subjective conclusion it is possible to see the improvement in physical form and health.
A big part of cancer patients were satisfied with the preparation and their assessment was positive. The choice of patients wasn’t fully homogeneous because the period of use wasn’t equally long, as the patients were with different diagnosis of cancer at different stages of the disease. The preparation has been used for cancer therapy as an addition to conventional treatment. While we can say that it is more suitable in the early stages of the disease and during the chemotherapy or radiotherapy. At patients with metastases it has a short-term effect. PENOXAL has always used with the recommended oncological treatment, at the patients has also observed an obviously short period of adaptation to classical chemotherapy and rather quick recovery. The preparation PENOXAL is an effective supporting remedy at oncological diseases.
Prim. MUDr. Zdeněk Janáček